We observed that knockdown of KDM2B alone reduces the proliferation rate of GBM cells in long term (Figure 6b), while within short term of 24 h the proliferation rate is comparable with control cells, confirming our previous observation (Figure 2d). This evidence concerns the gene KDM2B and glioblastoma.